Jacobio Pharmaceuticals Group Co Lt (1167)

Hong Kong
12.30
+0.18(+1.49%)
  • Volume:
    48,000
  • Bid/Ask:
    12.30/12.38
  • Day's Range:
    12.12 - 12.60

1167 Overview

Prev. Close
12.12
Day's Range
12.12-12.6
Revenue
666.61M
Open
12.6
52 wk Range
12.02-25.35
EPS
-1.36
Volume
48,000
Market Cap
9.49B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
291,426
P/E Ratio
-
Beta
-
1-Year Change
-35.87%
Shares Outstanding
771,462,180
Next Earnings Date
-
What is your sentiment on Jacobio Pharmaceuticals Group Co Lt?
or
Market is currently closed. Voting is open during market hours.

Jacobio Pharmaceuticals Group Co Lt Company Profile

Employees
213
Market
Hong Kong

Jacobio Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, focusing on the in-house discovery and development of oncology therapies. The company’s lead drug development programs include two clinical-stage allosteric SHP2 inhibitors comprising JAB-3068 and JAB-3312 for the treatment of esophageal cancer; JAB-8263, a small molecule inhibitor of BET family proteins regulating MYC transcription to treat various cancers; and JAB-21822, an oral small molecule targeting mutant KRAS G12C protein. It is also developing JAB-BX102, a humanized inhibitory antibody against human CD73 for the treatment of PD-1 resistant cancer; JAB-6343, an inhibitor that targets fibroblast growth factor receptor 4 for advanced hepatocellular carcinoma with FGF19 overexpression; JAB-2485, an aurora A kinase inhibitor to treat various RB1-deficient tumors; JAB-24000, a tumor metabolic pathway for the treatment of solid tumors; and JAB-BX300, a molecule antibody targeting RAS pathway to treat pancreatic and other solid tumors with KRAS mutations. The company has a strategic collaboration with AbbVie Ireland Unlimited Company to develop and commercialize SHP2 inhibitors. Jacobio Pharmaceuticals Co., Ltd. was incorporated in 2015 and is headquartered in Beijing, China.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralSellStrong SellSell
Technical IndicatorsSellStrong BuyStrong SellStrong SellStrong Sell
SummarySellBuyStrong SellStrong SellStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.